Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1936 1
1938 1
1945 1
1947 1
1954 1
1959 1
1960 1
1961 1
1964 1
1968 1
1969 1
1970 1
1978 1
1983 2
1984 5
1985 6
1986 10
1987 4
1988 6
1989 4
1990 5
1991 3
1993 2
1995 1
1996 3
1997 2
1998 6
1999 15
2000 3
2001 4
2002 2
2003 1
2004 2
2005 3
2006 2
2007 3
2008 7
2009 7
2010 13
2011 6
2012 8
2013 6
2014 9
2015 7
2016 9
2017 8
2018 6
2019 9
2020 5
2021 4
2022 3
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Stage au Gabon, une expérience de formation hors du commun.
Besson C, Brilhaut M, Bristot A, Deau A, Deandrade J, Phulpin J, Talbot G. Besson C, et al. Among authors: talbot g. Rev Infirm. 2017 Mar;66(229):51-52. doi: 10.1016/j.revinf.2016.12.036. Rev Infirm. 2017. PMID: 28284413 French. No abstract available.
The Fight Against Multidrug-Resistant Bacteria.
Boucher HW, Cosgrove SE, Cox E, Talbot GH. Boucher HW, et al. Among authors: talbot gh. Ann Intern Med. 2017 Jan 3;166(1):78-79. doi: 10.7326/L16-0584. Ann Intern Med. 2017. PMID: 28030674 No abstract available.
Achromobacter xylosoxidans bacteremia.
McGann KA, Provencher M, Hoegg C, Talbot GH. McGann KA, et al. Among authors: talbot gh. Infect Control Hosp Epidemiol. 1990 Oct;11(10):539-41. doi: 10.1086/646088. Infect Control Hosp Epidemiol. 1990. PMID: 2230043 Review. No abstract available.
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Tivey A, Shotton R, Eyre TA, Lewis D, Stanton L, Allchin R, Walter H, Miall F, Zhao R, Santarsieri A, McCulloch R, Bishton M, Beech A, Willimott V, Fowler N, Bedford C, Goddard J, Protheroe S, Everden A, Tucker D, Wright J, Dukka V, Reeve M, Paneesha S, Prahladan M, Hodson A, Qureshi I, Koppana M, Owen M, Ediriwickrema K, Marr H, Wilson J, Lambert J, Wrench D, Burney C, Knott C, Talbot G, Gibb A, Lord A, Jackson B, Stern S, Sutton T, Webb A, Wilson M, Thomas N, Norman J, Davies E, Lowry L, Maddox J, Phillips N, Crosbie N, Flont M, Nga E, Virchis A, Camacho RG, Swe W, Pillai A, Rees C, Bailey J, Jones S, Smith S, Sharpley F, Hildyard C, Mohamedbhai S, Nicholson T, Moule S, Chaturvedi A, Linton K. Tivey A, et al. Among authors: talbot g. Blood Adv. 2024 Mar 12;8(5):1209-1219. doi: 10.1182/bloodadvances.2023011152. Blood Adv. 2024. PMID: 38127279 Free PMC article.
201 results